Potential ethical issues with the commercial
One of the most important and general principles regarding product promotion is that we may not promote or pre-sell products that have not been approved or approved by the appropriate regulatory agency for the location or use. If a healthcare professional inquires about the use of an Abbott product beyond the approved label (sometimes referred to as an "off-label" use), the inquiry should be referred to the appropriate agency in your business area.
We must always exercise caution when dealing with competitors. You should not discuss sensitive business matters such as pricing, terms of sale, business or marketing plans, margins, costs, production capacity, inventory or discounts with competitors. You should contact the Legal Department or the Office of Ethics and Compliance for specific guidance on the law regarding your interactions with competitors and to report inappropriate conversations with competitors.
Abbott is looking for a new virus to fight
The history of global virus hunting -- and the future dedicated to furthering this important work. As a leader in blood screening and infectious disease testing, Abbott established a global viral surveillance program more than 25 years ago to detect and identify mutations in HIV and hepatitis viruses, helping to ensure the company's diagnostic tests are accurate enough to stay current and Empowering researchers to proactively assess and address infectious disease-related challenges. The surveillance program will now be part of the Abbott Pandemic Defense Alliance.
Drawing on decades of virus surveillance experience, Abbott designs its tests, including the COVID-19 test, with the evolution of the virus in mind. When new strains are discovered, Abbott analyzes them extensively to ensure their diagnostic tests pick them up. The consortium is providing networking to collaborate with other leading institutions on this work.
Commercial promotes abbott's new virus fighting product
As virus cases in the U.S. plummeted this spring, sales of Abbott's Covid tests also fell. But now, amid a new wave of infections, the company's steps to eliminate stockpiles and shut down production are proving ill-timed -- hampering efforts to expand screening as the highly contagious Delta variant spreads across the country wreaks havoc within.
Demand for the 15-minute BinaxNOW Antigen Test is on the rise again as people return to schools and offices. But Abbott has reportedly told thousands of newly interested companies that it cannot equip their testing programs anytime soon. CVS, Rite Aid and Walgreens stores are all sold out, and Amazon is showing delivery delays of up to three weeks. Abbott is trying to reinstate hundreds of workers.
- advertisement spot 2023